£20m research boost will help develop new medicines and digital tools to drive weight loss
Obesity costs the NHS more than £6billion a year
Cutting-edge obesity treatments and technologies which can help people shed 20% of their weight could soon be offered to NHS patients, following the announcement of a £20m research boost by the Government.
Obesity costs the NHS £6billion a year, and this figure is set to rise to over £9.7billion each year by 2050.
The new investment, announced this week, is expected to save the NHS billions over time and ensure that vital funds are spent on key frontline services.
The fund could lead to promising medicines and digital technologies being made available to patients, such as apps and online portals to encourage lifestyle changes, which have been shown in clinical trials to be safe and lead to a significant reduction in weight.
Health and Social Care Secretary, Steve Barclay, said: “Having a fit and healthy population is essential to reducing pressure on the NHS and supporting the economy with obesity, currently estimated to cost the NHS nearly £10billion per year by 2050.
“We are fast-tracking the most-promising treatments and technologies to NHS patients to help them achieve a healthy weight, save the NHS billions of pounds, and increase life expectancy.
“We are determined to harness the full potential of innovative medical breakthroughs to level up the health of the nation.”
An open competition will be run in early 2023 to identify sites to deliver this research, exploring how new and potentially-transformative medicines can be combined with technologies such as digital tools to improve long-term health outcomes for people living with obesity.
We are fast-tracking the most-promising treatments and technologies to NHS patients to help them achieve a healthy weight, save the NHS billions of pounds, and increase life expectancy
Research will be focused outside of London and the Greater South East, in the areas where obesity rates and health disparities are highest.
The news comes after the Government announced earlier this week that a Vaccine Taskforce approach will be used to tackle some of the leading public health issues which damage the economy and drain NHS resources.
Four healthcare missions will be covered – obesity, cancer, mental health, and addiction, aimed at quickly developing and delivering new treatments, technology, and support to patients to help them lead longer, healthier lives.
This builds upon the UK Life Sciences Vision published in July 2021 which sets out a 10-year strategy to harness the successes of the COVID-19 response and accelerate the delivery of innovation to patients.